Evidence map›Paper›PMID 29789561›Full record

ArticleNature communications2018

L-SCRaMbLE as a tool for light-controlled Cre-mediated recombination in yeast.

Lena Hochrein, Leslie A Mitchell, Karina Schulz, Katrin Messerschmidt, Bernd Mueller-Roeber

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
26.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 112 citations in OpenAlex.

  1. Development and characterization of a Cre/Synthetic and systems biotechnology · 2027
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Rational evolution for altering the ligand preference of estrogen receptor alpha.Protein science : a publication of the Protein Society · 2024
    Article
  13. Article
  14. Article
  15. Practical Approaches for the YeastInternational journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Lena HochreinCell2Fab Research Unit, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany.
Leslie A MitchellInstitute for Systems Genetics, New York University Langone School of Medicine, New York City, NY, 10016, USA.
Karina SchulzCell2Fab Research Unit, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany.
Katrin MesserschmidtCell2Fab Research Unit, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany.
Bernd Mueller-RoeberDepartment of Molecular Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany. bmr@uni-potsdam.de.
University of Potsdam · DENew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthetic yeast genome constructed by the International Synthetic Yeast Sc2.0 consortium adds thousands of loxPsym recombination sites to all 16 redesigned chromosomes, allowing the shuffling of Sc2.0 chromosome parts by the Cre-loxP recombination system thereby enabling genome evolution experiments. Here, we present L-SCRaMbLE, a light-controlled Cre recombinase for use in the yeast Saccharomyces cerevisiae. L-SCRaMbLE allows tight regulation of recombinase activity with up to 179-fold induction upon exposure to red light. The extent of recombination depends on induction time and concentration of the chromophore phycocyanobilin (PCB), which can be easily adjusted. The tool presented here provides improved recombination control over the previously reported estradiol-dependent SCRaMbLE induction system, mediating a larger variety of possible recombination events in SCRaMbLE-ing a reporter plasmid. Thereby, L-SCRaMbLE boosts the potential for further customization and provides a facile application for use in the S. cerevisiae genome re-engineering project Sc2.0 or in other recombination-based systems.

Indexed as

Genome, FungalClone CellsGene EditingGene ExpressionGenes, SyntheticGenetic EngineeringIntegrasesLightPhycobilinsPhycocyaninPlasmidsRecombination, GeneticSaccharomyces cerevisiaeSelection, GeneticCre recombinaseIntegrasesPhycobilinsPhycocyaninphycocyanobilin

Identifiers

PMID29789561
PMCPMC5964156
OpenAlexW2804051240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.